Jazz Pharmaceuticals plc - SHS USD (JAZZ)

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / SHS USD
Total 13F shares
56,253,036
Share change
-193,630
Total reported value
$7,906,867,974
Put/Call ratio
236%
Price per share
$140.56
Number of holders
338
Value change
-$16,787,687
Number of buys
155
Number of sells
189

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2015

As of 31 Dec 2015, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 338 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,253,036 shares. The largest 10 holders included PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, JANUS CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, and HERNDON CAPITAL MANAGEMENT LLC. This page lists 338 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.